R1 RCM (NASDAQ: RCM)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of R1 RCM (NASDAQ: RCM) through any online brokerage.
There are no as such competitors for R1 RCM.
The latest price target for R1 RCM (NASDAQ: RCM) was reported by Deutsche Bank on Wednesday, June 29, 2022. The analyst firm set a price target for 26.00 expecting RCM to rise to within 12 months (a possible 14.79% upside). 8 analyst firms have reported ratings in the last year.
The stock price for R1 RCM (NASDAQ: RCM) is $22.65 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for R1 RCM.
R1 RCM’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for R1 RCM.
R1 RCM is in the Healthcare sector and Health Information Services industry. They are listed on the NASDAQ.